Callahan Advisors, LLC Gilead Sciences, Inc. Transaction History

Callahan Advisors, LLC

$929 Million
Q2 2024

A detailed history of Callahan Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Callahan Advisors, LLC holds 4,119 shares of GILD stock, worth $345,790. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,119

Previous 3,111 32.4%

Holding current value

$345,790

Previous $227,000 24.23%

% of portfolio

0.03%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$63.15 - $72.88 $63,655 - $73,463	1,008 Added 32.4%	4,119 $282,000
Q1 2024 Apr 24, 2024	BUY	$71.58 - $87.29 $572 - $698	8 Added 0.26%	3,111 $227,000
Q4 2023 Jan 24, 2024	BUY	$73.27 - $83.09 $439 - $498	6 Added 0.19%	3,103 $251,000
Q3 2023 Oct 23, 2023	BUY	$73.94 - $80.67 $517 - $564	7 Added 0.23%	3,097 $232,000
Q2 2023 Jul 31, 2023	SELL	$76.01 - $86.7 $37,472 - $42,743	-493 Reduced 13.76%	3,090 $238,000
Q1 2023 Apr 28, 2023	SELL	$77.31 - $88.08 $11,132 - $12,683	-144 Reduced 3.86%	3,583 $297,000
Q4 2022 Feb 03, 2023	BUY	$62.32 - $89.47 $1,682 - $2,415	27 Added 0.73%	3,727 $319,000
Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $535 - $612	9 Added 0.24%	3,700 $228,000
Q2 2022 Jul 29, 2022	BUY	$57.72 - $65.01 $519 - $585	9 Added 0.24%	3,691 $228,000
Q1 2022 Apr 27, 2022	BUY	$57.92 - $72.58 $213,261 - $267,239	3,682 New	3,682 $219,000
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $185,881 - $210,978	-2,865 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$67.69 - $73.03 $193,931 - $209,230	2,865 New	2,865 $200,000
Q1 2021 Apr 21, 2021	SELL	$60.0 - $68.46 $230,580 - $263,091	-3,843 Closed	0 $0
Q4 2020 Jan 20, 2021	BUY	$56.65 - $64.55 $11,726 - $13,361	207 Added 5.69%	3,843 $224,000
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $38,998 - $49,034	-628 Reduced 14.73%	3,636 $230,000
Q2 2020 Jul 17, 2020	SELL	$72.34 - $84.0 $25,970 - $30,156	-359 Reduced 7.77%	4,264 $328,000
Q1 2020 Apr 06, 2020	SELL	$62.63 - $80.22 $37,264 - $47,730	-595 Reduced 11.4%	4,623 $346,000
Q4 2019 Jan 21, 2020	SELL	$61.62 - $67.78 $30,440 - $33,483	-494 Reduced 8.65%	5,218 $339,000
Q3 2019 Oct 21, 2019	SELL	$62.51 - $69.0 $58,384 - $64,446	-934 Reduced 14.05%	5,712 $362,000
Q2 2019 Jul 17, 2019	SELL	$61.87 - $69.38 $166,677 - $186,909	-2,694 Reduced 28.84%	6,646 $449,000
Q1 2019 Apr 22, 2019	SELL	$62.53 - $70.05 $1.02 Million - $1.14 Million	-16,244 Reduced 63.49%	9,340 $607,000
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $175,263 - $228,705	-2,895 Reduced 10.17%	25,584 $1.6 Million
Q3 2018 Oct 15, 2018	SELL	$71.28 - $78.92 $3.81 Million - $4.22 Million	-53,497 Reduced 65.26%	28,479 $2.2 Million
Q2 2018 Jul 19, 2018	SELL	$64.88 - $75.68 $263,737 - $307,639	-4,065 Reduced 4.72%	81,976 $5.81 Million
Q1 2018 Apr 30, 2018	BUY	$72.84 - $88.8 $174,306 - $212,498	2,393 Added 2.86%	86,041 $6.49 Million
Q4 2017 Jan 31, 2018	SELL	$71.15 - $83.52 $455,929 - $535,196	-6,408 Reduced 7.12%	83,648 $5.99 Million
Q3 2017 Oct 26, 2017	BUY	$72.11 - $85.47 $6.49 Million - $7.7 Million	90,056	90,056 $7.3 Million

Others Institutions Holding GILD

# of Institutions

1,878

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Callahan Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callahan Advisors, LLC with notifications on news.

Account

Callahan Advisors, LLC Gilead Sciences, Inc. Transaction History